106 related articles for article (PubMed ID: 25320755)
1. Metformin and prognosis of critical illness: a question of timing?
Christiansen CF
Crit Care; 2013; 17(6):471. PubMed ID: 25320755
[No Abstract] [Full Text] [Related]
2. Metformin improves survival in intensive care unit patients, but why?
Riksen NP; Rongen GA; Pickkers P
Crit Care; 2013 Dec; 17(6):471. PubMed ID: 24330731
[No Abstract] [Full Text] [Related]
3. Hyperglycemia in the intensive care unit: is insulin the only option?
Dungan KM
Crit Care; 2013 Nov; 17(6):1012. PubMed ID: 25169675
[TBL] [Abstract][Full Text] [Related]
4. Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study.
Christiansen C; Johansen M; Christensen S; O'Brien JM; Tønnesen E; Sørensen H
Crit Care; 2013 Sep; 17(5):R192. PubMed ID: 24018017
[TBL] [Abstract][Full Text] [Related]
5. The UK Prospective Diabetes Study.
Evans M
Lancet; 1998 Dec; 352(9144):1932-3; author reply 1934. PubMed ID: 9863807
[No Abstract] [Full Text] [Related]
6. The UK Prospective Diabetes Study.
Bailey CJ; Grant PJ
Lancet; 1998 Dec; 352(9144):1932; author reply 1934. PubMed ID: 9863806
[No Abstract] [Full Text] [Related]
7. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.
Lamanna C; Monami M; Marchionni N; Mannucci E
Diabetes Obes Metab; 2011 Mar; 13(3):221-8. PubMed ID: 21205121
[TBL] [Abstract][Full Text] [Related]
8. Metformin as firstline treatment for type 2 diabetes: are we sure?
Boussageon R; Gueyffier F; Cornu C
BMJ; 2016 Jan; 352():h6748. PubMed ID: 26747716
[TBL] [Abstract][Full Text] [Related]
9. Mortality risk with sulphonylureas compared to metformin.
Holden SE; Currie CJ
Diabetes Obes Metab; 2014 Oct; 16(10):885-90. PubMed ID: 24533964
[TBL] [Abstract][Full Text] [Related]
10. Oral pharmacologic treatment of type 2 diabetes mellitus.
Richard T; Brohee D; Van Meerhaeghe A; Vanhaeverbeek M
Ann Intern Med; 2012 Jul; 157(1):76; author reply 76-7. PubMed ID: 22751769
[No Abstract] [Full Text] [Related]
11. Oral pharmacologic treatment of type 2 diabetes mellitus.
Rodbard HW; Jellinger PS
Ann Intern Med; 2012 Jul; 157(1):75-6; author reply 76-7. PubMed ID: 22751768
[No Abstract] [Full Text] [Related]
12. Oral pharmacologic treatment of type 2 diabetes mellitus.
Moskowitz RS
Ann Intern Med; 2012 Jul; 157(1):75; author reply 76-7. PubMed ID: 22751767
[No Abstract] [Full Text] [Related]
13. Starting titrating and intensifying metformin.
Kalra S; Gupta Y
J Pak Med Assoc; 2015 Jul; 65(7):799-800. PubMed ID: 26160097
[TBL] [Abstract][Full Text] [Related]
14. [Metformin is commonly used in patients with renal impairment].
Alscher MD
Dtsch Med Wochenschr; 2015 Nov; 140(22):1656. PubMed ID: 26536639
[No Abstract] [Full Text] [Related]
15. [Blood glucose control with high dosage metformin. So that sweet hearts beat longer].
MMW Fortschr Med; 2002 Jun; 144(24):46-7. PubMed ID: 12138888
[No Abstract] [Full Text] [Related]
16. Continuation of metformin after introduction of insulin in type 2 diabetes.
Kooy A
BMJ; 2009 Nov; 339():b4227. PubMed ID: 19900992
[No Abstract] [Full Text] [Related]
17. Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study.
Sillars B; Davis WA; Hirsch IB; Davis TM
Diabetes Obes Metab; 2010 Sep; 12(9):757-65. PubMed ID: 20649627
[TBL] [Abstract][Full Text] [Related]
18. Metformin use in patients with diabetes mellitus and heart failure: friend or foe?
Giamouzis G; Triposkiadis F; Butler J
J Card Fail; 2010 Mar; 16(3):207-10. PubMed ID: 20206894
[No Abstract] [Full Text] [Related]
19. [Metabolism control in overweight type 2 diabetics. High metformin dosage brings more].
MMW Fortschr Med; 2001 Nov; 143(44):56. PubMed ID: 11732400
[No Abstract] [Full Text] [Related]
20. Single-composition extended-release metformin hydrochloride. A viewpoint by Vivian Fonseca.
Fonseca V
Treat Endocrinol; 2004; 3(5):333-4. PubMed ID: 15330684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
